Evaluation of radiotheraphy response of cervical carcinoma with gray scale and color Doppler ultrasonography: Resistive index correlation with magnetic resonance findings

Diagnostic and Interventional Radiology

Volumn 12, Issue 3, 2006, Pages 155-160

  Kerimoǧlu, Ülkü ^a   Akata, Deniz ^a   Hazirolan, Tuncay ^a   Ergen, Fatma B ^a   Köse, Faruk ^b   Özyar, Enis ^a   Atahan, Lale I ^a   Akhan, Okan ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b Training Hospital   (Turkey)

Author keywords

Cervix carcinoma; Color Doppler ultrasound; Response to therapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; B SCAN; BLADDER METASTASIS; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; FEMALE; GRAY SCALE ECHOGRAPHY; HUMAN; INTERMETHOD COMPARISON; MEDICAL ASSESSMENT; MINIMAL RESIDUAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; RADIOSENSITIVITY; RECTUM CANCER; SENSITIVITY AND SPECIFICITY; TRANSVAGINAL ECHOGRAPHY; TREATMENT OUTCOME; TREATMENT RESPONSE; UTERINE CERVIX CARCINOMA; ADJUVANT CHEMOTHERAPY; CARCINOMA; COMPARATIVE STUDY; ECHOGRAPHY; MIDDLE AGED; PATHOLOGY; UTERINE CERVIX TUMOR; VAGINA;

ADULT; AGED; CARCINOMA; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM STAGING; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, COLOR; UTERINE CERVICAL NEOPLASMS; VAGINA;

EID: 33748580682     PISSN: 13053825     EISSN: 13053612     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Pakkal MV, Rudralingam V, McCluggage WG, Kelly BE. MR staging in carcinoma of the endometrium and carcinoma of the cervix. Ulster Med J 2004; 73:20-24.
2. Chiang SH, Quek ST. Carcinoma of the cervix: role of MR imaging. Ann Acad Med Singapore 2003; 32:550-556.
3. Ozsarlak O, Tjalma W, Schepens E, et al. The correlation of preoperative CT, MR imaging, and clinical staging (FIGO) with histopathology findings in primary cervical carcinoma. Eur Radiol 2003; 13:2338-2345.
4. Delagado G, Bundy BN, Fowler WC, et al. A prospective surgical pathological study of stage I squamous carcinoma of the cervix: A gynecologic oncology group study. Gynecol Oncol 1989; 35:314-320.
5. Folkman J. Anti-angiogenesis: New concept for therapy of solid tumors. Ann Surg 1972; 175:409-416.
6. Alcazar JL, Jurado M. Transvaginal color doppler for predicting pathological response to preoperative chemoradiation in locally advanced cervical carcinoma: a preliminary study. Ultrasound Med Biol 1999; 25:1041-1045.
7. Cheng WF, Lee CN, Chu JS. Vascularity index as a novel parameter for the in vivo assessment of angiogenesis in patients with cervical carcinoma. Cancer 1999; 85:651-657.
8. Wu UC, Yuan CC, Hung JH, et al. Power doppler angiographic appearance and blood flow velocity waveforms in invasive cervical carcinoma. Gynecol Oncol 2000; 79:181-186.
9. Teper R, Zalel Y, Altaras M, Ben-Brauch G, Beyth Y. Transvaginal color doppler ultrasound in the assessment of invasive cervical carcinoma. Gynecol Oncol 1996; 60:26-29.
10. Wiggins DL, Granai CO, Steinhoff MM. Tumor angiogenesis as prognostic factor in cervical carcinoma. Gynecol Oncol 1995; 56:353-356.
11. Teper R, Shulman A, Altaras M, et al. The role of color doppler flow in the management of nonmetastatic gestational trophoblastic disease. Gynecol Obstet Invest 1994; 38:14-17.
12. Hata K, Makihara K, Hata T, Takahashi K, Kitao M. Transvaginal color doppler imaging for hemodynamic assessment of tumors in the reproductive tract. Int J Gynecol Obstet 1991; 36:301-308.
13. Basil JB, Horowitz IR. Cervical carcinoma contemrorary manegement. Obstet Gynecol Clin North Am 2001; 28:727-742.
14. Scheidler J, Henck AF. Imaging of cancer of cervix. Radiol Clin North Am 2002; 40: 577-590.
15. Manfredi R, Maresca G, Smaniotto D, et al. Cervical cancer response to neoadjuvant therapy: MR imaging assessment. Radiology 1998; 209:819-824.
16. Okada S, Cho K, Amano M, et al. Uterine cervical carcinoma after radiotherapy: comparison between MR imaging and histopathological findings. Nippon Igaku Hoshasen Gakkai Zasshi 1997; 57:23-27.
17. Mayr NA, Yuh WT, Zheng J, et al. Prediction of tumor control in patients with cervical cancer: analysis of combined volume and dynamic enhancement pattern by MR imaging. AJR Am J Roentgenol 1998; 170:177-182.
18. Yamano T, Takayasu Y, Inoue J, et al. Evaluation by MR imaging of neoadjuvant intra-arterial infusion chemotherapy in uterine cervical cancer. Gan To Kagaku Ryoho 1998; 25: 1322-1325.
19. Cheng WF, Wei LH, Su YN. The possible use of colour flow Doppler in planning treatment in early invasive carcinoma of the cervix. Br J Obstet Gynaecol 1999; 106:1137-1142.
20. Cheng WF, Lee CN, Chen CA, et al. Comparison between 'in vivo' and 'in vitro' methods for evaluating tumor angiogenesis using cervical carcinoma as a model. Angiogenesis 1999; 3: 295-304
21. Alcazar JL, Castillo G, Martinez-Monge R, Jurado M. Transvaginal color Doppler sonography for predicting response to concurrent chemotherapy for locally advanced cervical carcinoma. J Clin Ultrasound 2004; 32:267-272.
22. Testa AC, Ferrandina G, Distefano M, et al. Color Doppler velocimetry and three-dimensional color power angiography of cervical carcinoma. Ultrasound Obstet Gynecol 2004; 24:445-452.
23. Sironi S, Belloni C, Taccagni GL, Calabresi P, Del Maschio A. Invasive cervical carcinoma: MR imaging after preoperative chemotherapy. Radiology 1991; 180:719-722.
24. Santoni R, Bucciolini M, Chiostrini C, Cionini L, Renzi R. Quantitative MR imaging in cervical carcinoma: a report on 30 cases. Br J Radiol 1991; 64:498-504.
25. Mary NA, Yuh WT, Zheng J, et al, Hussey DH. Prediction of tumor control in patients with cervical cancer: analysis of combined volume and dynamic enhancement pattern by MR imaging. AJR Am J Roentgenol 1998; 170:177-82.
26. Yamano T, Takayasu Y, Inoue J, et al. Evaluation by MR imaging of neoadjuvant intra-arterial infusion chemotherapy in uterine cervical cancer. Gan To Kagaku Ryoho 1998; 25: 1322-5.
27. Alcazar JL, Castillo G, Jurado M, Lopez-Garcia G. Intratumoral blood flow in cervical cancer as assessed by transvaginal color doppler ultrasonography: Correlation with tumor characteristics. Int J Gynecol Cancer 2003; 13:510-514.